Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery
Status:
Terminated
Trial end date:
2014-12-15
Target enrollment:
Participant gender:
Summary
This study is being done to determine if lidocaine, administered during surgery and for 24
hours after surgery can reduce inflammation, thereby reducing the risk of atrial fibrillation
and 30 day mortality after surgery. Participants undergoing cardiac surgery will be
randomized to receive either lidocaine or placebo.